Displaying 1–25 of 780 results for Pharma Manufacturing staff
Exploring best-practice manufacturing strategies for highly potent oral solid dosage forms
The annual Pharma Innovation Awards are our brand's way of acknowledging the investment pharmaceutical equipment vendors put into developing and improving their products.
FDA looks to improve transparency and predictability for generic drug applicants.
Pfizer is shifting its attention to remoter regions of China in an effort to offset the impact of government price-cutting policies on sales of its aging blockbusters.
Pharma Manufacturing sat down with tableting expert, Alex Bunting, I Holland, to discuss common tablet manufacturing problems and fixes.
Whatever their intended purpose, setting up a cleanroom requires careful consideration both in the design phase, and then in how you use it.
The announcement this week that FDA Commissioner, Scott Gottlieb, will be leaving his post came as a surprise to many in the industry.
Why manufacturers are seeking alternative options to in-house preparation.
Putman Media's Influential Women in Manufacturing program is now accepting nominations for 2019 honorees
The importance of laboratory research to the pharmaceutical industry cannot be overstated. The pharma lab makes essential contributions in product/process development and process improvement, setting the stage for successful scale up and commercialization.
The EU’s drug regulator is within weeks of moving its staff and operations from London to Amsterdam.
A U.S. FDA advisory panel to the voted 8-8 over whether to recommend approval of a treatment for type 1 diabetes developed by Sanofi and Lexicon Pharmaceuticals.
About 100 of the returning staff will be concentrating on inspections of high-risk medical device manufacturing facilities, about 70 focused on inspections of high-risk drug manufacturing facilities and about 90 focused on inspections of high-risk biological manufacturing facilities
New WalletHub analysis ranks 2019’s Best & Worst Metro Areas for STEM Professionals
A mix of the biggest hits from 2018
As Pharmaceutical Manufacturing sends its final issue of 2018 to the printer, we’d like to take this opportunity to reflect on some of our favorite highlights:
In an environment characterized by increasingly demanding production requirements driven by machinery composed of numerous mechanical parts, choosing the most efficient plastics and sealing components is critical.
An elderly Pennsylvania couple, know for their personal crusade against McNeil Consumer Healthcare, was found dead outside their home.
Pharma companies can now become demand-driven, synchronizing supply to demand to optimize patient service levels, lower inventory levels, and reduce costs
Key trends highlighted at this year’s CPhI Worldwide
Top five sights from our Netherlands biopharma industry tour
Survey results reveal how slow-motion trends are driving biopharma growth.
AstraZeneca will gain an 8 percent ownership stake in Sobi with the deal's total value reaching $2.3 billion when including deferred and contingency payments.
An advisory panel to the U.S. FDA voted against approving Alkermes’ treatment for depression in patients with an inadequate response to standard antidepressant therapies.